SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS‐CoV‐2–host interactomes and provided great resources for understanding viral replica...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, Taras Redchuk, Mariia Bogacheva, Kari Salokas, Ina Pöhner, Tiina Öhman, Arun Kumar Tonduru, Antti Hassinen, Lisa Gawriyski, Salla Keskitalo, Maria K Vartiainen, Vilja Pietiäinen, Antti Poso, Markku Varjosalo
Format: article
Language:EN
Published: Wiley 2021
Subjects:
drug discovery
mass spectrometry
proteomics
SARS‐CoV‐2
virus–host interactions
Biology (General)
QH301-705.5
Medicine (General)
R5-920
Online Access:https://doaj.org/article/c87ddbd7671244cc9c1ca8b5b5555d62
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c87ddbd7671244cc9c1ca8b5b5555d62

Similar Items